Search Results - "Pilishvili, Tamara"
-
1
Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020
Published in MMWR. Morbidity and mortality weekly report (10-04-2020)“…As of April 2, 2020, the coronavirus disease 2019 (COVID-19) pandemic has resulted in >890,000 cases and >45,000 deaths worldwide, including 239,279 cases and…”
Get full text
Journal Article Newsletter -
2
Genome-wide association analyses of invasive pneumococcal isolates identify a missense bacterial mutation associated with meningitis
Published in Nature communications (14-01-2019)“…Bacterial mutations predisposing pneumococcus to causing meningitis, a more severe form of invasive pneumococcal disease (IPD), are largely unknown. Knowledge…”
Get full text
Journal Article -
3
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
Published in The Journal of infectious diseases (01-01-2010)“…BackgroundChanges in invasive pneumococcal disease (IPD) incidence were evaluated after 7 years of 7-valent pneumococcal conjugate vaccine (PCV7) use in US…”
Get full text
Journal Article -
4
Assessment of traditional and improved stove use on household air pollution and personal exposures in rural western Kenya
Published in Environment international (01-02-2017)“…Over 40% of the world's population relies on solid fuels for heating and cooking. Use of improved biomass cookstoves (ICS) has the potential to reduce…”
Get full text
Journal Article -
5
Geographic Differences in COVID-19 Cases, Deaths, and Incidence - United States, February 12-April 7, 2020
Published in MMWR. Morbidity and mortality weekly report (17-04-2020)“…Community transmission of coronavirus disease 2019 (COVID-19) was first detected in the United States in February 2020. By mid-March, all 50 states, the…”
Get full text
Journal Article Newsletter -
6
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021
Published in MMWR. Morbidity and mortality weekly report (27-08-2021)“…Nursing home and long-term care facility residents live in congregate settings and are often elderly and frail, putting them at high risk for infection with…”
Get full text
Journal Article Newsletter -
7
Effectiveness of Six Improved Cookstoves in Reducing Household Air Pollution and Their Acceptability in Rural Western Kenya
Published in PloS one (15-11-2016)“…Household air pollution (HAP) from biomass fuel burning is linked to poor health outcomes. Improved biomass cookstoves (ICS) have the potential to improve HAP…”
Get full text
Journal Article -
8
Nasopharyngeal carriage of Streptococcus pneumoniae among children <5 years of age in Indonesia prior to pneumococcal conjugate vaccine introduction
Published in PloS one (11-01-2024)“…Pneumococcal conjugate vaccines (PCVs) prevent nasopharyngeal colonization with vaccine serotypes of Streptococcus pneumoniae, leading to reduced transmission…”
Get full text
Journal Article -
9
Impact of 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease Among Adults With HIV—United States, 2008–2018
Published in Journal of acquired immune deficiency syndromes (1999) (01-05-2022)“…People with HIV (PWH) are at increased risk for invasive pneumococcal disease (IPD). Thirteen-valent pneumococcal conjugate vaccine (PCV13) was recommended for…”
Get full text
Journal Article -
10
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022
Published in MMWR. Morbidity and mortality weekly report (02-12-2022)“…On September 1, 2022, bivalent COVID-19 mRNA vaccines, composed of components from the SARS-CoV-2 ancestral and Omicron BA.4/BA.5 strains, were recommended by…”
Get full text
Journal Article Newsletter -
11
A Population-Based Descriptive Atlas of Invasive Pneumococcal Strains Recovered Within the U.S. During 2015-2016
Published in Frontiers in microbiology (19-11-2018)“…Invasive pneumococcal disease (IPD) has greatly decreased since implementation in the U.S. of the 7 valent conjugate vaccine (PCV7) in 2000 and 13 valent…”
Get full text
Journal Article -
12
Systematic Review and Meta-Analysis of the Efficacy and Effectiveness of Pneumococcal Vaccines in Adults
Published in Pathogens (Basel) (19-05-2023)“…New pneumococcal conjugate vaccines (PCVs), 15- and 20-valent (PCV15 and PCV20), have been licensed for use among U.S. adults based on safety and…”
Get full text
Journal Article -
13
Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine
Published in The New England journal of medicine (01-05-2003)“…In 2000, a protein–polysaccharide pneumococcal conjugate vaccine was recommended for use in infants and young children. Surveillance data show that from 1998…”
Get full text
Journal Article -
14
Penicillin Resistance of Nonvaccine Type Pneumococcus before and after PCV13 Introduction, United States
Published in Emerging infectious diseases (01-06-2017)“…Introduction of 13-valent pneumococcal conjugate vaccine in the United States was not associated with a significant change in prevalence of penicillin…”
Get full text
Journal Article -
15
Cost-effectiveness of implementing 13-valent pneumococcal conjugate vaccine for U.S. adults aged 19 years and older with underlying conditions
Published in Human vaccines & immunotherapeutics (03-07-2021)“…In June 2019, the Advisory Committee on Immunization Practices (ACIP) changed the recommendation for routine 13-valent pneumococcal conjugate vaccine (PCV13)…”
Get full text
Journal Article -
16
Invasive Pneumococcal Infections among Vaccinated Children in the United States
Published in The Journal of pediatrics (01-03-2010)“…Objective Because 7-valent pneumococcal conjugate vaccine (PCV7) is highly efficacious, pneumococcal infections in vaccinated children raise concerns about…”
Get full text
Journal Article -
17
Post-licensure surveillance of 13-valent pneumococcal conjugate vaccine (PCV13) in adults aged ⩾19 years old in the United States, Vaccine Adverse Event Reporting System (VAERS), June 1, 2012–December 31, 2015
Published in Vaccine (07-12-2016)“…Abstract Background The 13-valent pneumococcal conjugate vaccine (PCV13) was first recommended for use in adults aged ⩾19 years with immunocompromising…”
Get full text
Journal Article -
18
User Perspectives of Characteristics of Improved Cookstoves from a Field Evaluation in Western Kenya
Published in International journal of environmental research and public health (27-01-2016)“…Over half of the world's population uses biomass fuels; these households cook on open fires indoors, increasing their risk of adverse health effects due to…”
Get full text
Journal Article -
19
PCR-Based Quantitation and Clonal Diversity of the Current Prevalent Invasive Serogroup 6 Pneumococcal Serotype, 6C, in the United States in 1999 and 2006 to 2007
Published in Journal of Clinical Microbiology (01-03-2009)“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
20
Surveillance of Vaccination Coverage Among Adult Populations — United States, 2014
Published in MMWR. Surveillance summaries (05-02-2016)“…Overall, the prevalence of illness attributable to vaccine-preventable diseases is greater among adults than among children. Adults are recommended to receive…”
Get full text
Journal Article